Detalhe da pesquisa
1.
Infigratinib Mediates Vascular Normalization, Impairs Metastasis, and Improves Chemotherapy in Hepatocellular Carcinoma.
Hepatology
; 69(3): 943-958, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30575985
2.
Upregulated hPuf-A promotes breast cancer tumorigenesis.
Tumour Biol
; 34(5): 2557-64, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23625657
3.
Sorafenib/MEK inhibitor combination inhibits tumor growth and the Wnt/ßcatenin pathway in xenograft models of hepatocellular carcinoma.
Int J Oncol
; 54(3): 1123-1133, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30747223